ABM – Abbott2021-11-12T10:51:56-05:00

We are Your Vendor for Next Generation Protein Sequencing.

We have a track-record of success. Together, we have the potential to unlock new discoveries, fast-track projects and safeguard reproducibility with our novel technology. Getting started is easy, since we’re already set up as a vendor. So come get to know us.

How We Can Support R&D Goals at Abbott.

Abbott Stated Goals

From our conversations, and your public statements here’s what we understand your interests to be:

  • Generate groundbreaking products in medical devices, nutrition, and branded generic pharmaceuticals
  • Deliver better solutions to help people live their best lives
  • Innovative approaches to diagnostics

How Rapid Novor Can Help

With our next-generation protein sequencing technology and services here’s how we can help with your goals:

  • Ensure access to critical protein reagents and diagnostics to maintain a supply chain of reliable proteins
  • Reliably sequence antibodies for downstream engineering
  • Unlock new antibody discovery possibilities through our REpAb® and NovorIg™ platforms

Applications, Industries and Solutions.

Protein Engineering

Engineering made easy with the complete primary structure of your protein or antibody.
Antibody Engineering with REmAb

Antibody Discovery

From selection of candidates to validation, we’ve got you covered. Gain a direct insight into the native immune response.
Polyclonal Sequencing Technology

Antibodies and ADCs

Analyse novel targets, including post-translationally modified forms, with a strong link to cancer biology.

Immunoassays

Reproducibility is crucial, especially for antibodies that are frequented for standard assays.
Explore IVD

Results, Case Studies and Research.

Common Problems We Have Solved for Clients:

  • Securing your antibody supply
  • Reproducibility or unexpected behavior
  • Proof of concept studies
  • Recovering lost information
  • Isotype selection
  • Discovery: additional candidates, faster
  • Discovery: a mountain of b-cell sequencing data
  • Inability to look at the functional native immune response
  • Ability to handle any species
  • Reducing risk, saving troubleshooting

Why Choose Us for Your Next Breakthrough.

3000+ successful sequencing projects
20+ years of proteomics innovation
400+ clients served

Antibody Sequencing & Discovery Services.

Antibody Sequencing & Discovery Services.

REmAb®

Monoclonal antibody sequencing from small protein samples, no need for hybridoma or DNA information. Full sequence in record time..
Explore REmAb

REpAb®

Polyclonal antibody sequencing and antibody discovery service. Sequence antibodies from blood or a polyclonal mixture.
Explore REpAb

MATCHmAb

Antibody verification by real-time peptide mapping. Antibody sequence confirmation service for reproducibility.
Explore MATCHmAb

Other

Ask us about recombinant expression, non-antibody protein sequencing, intact mass, CDRs and PTM analysis services.

Reproducibility Guarantee.

An alarming number of researchers in the life sciences have noted that their key reagents produce unreliable binding data. Improve reliability using our first-in class REmAb® platform.

Protein Engineering.

Access to good antibodies is important for your downstream protein engineering. Use our monoclonal sequencing platform to obtain a sequence, or our polyclonal sequencing platform to discover novel antibodies.

Any Isotype, Any Species.

Using a proteomics based platform allows us to sequence any protein without prior knowledge or published database sequences. Get any sequence in just 1-2 weeks.

Discover the Possibilities.

Jennifer Crha, MSc
Senior Scientific Sales Executive

I’m your dedicated rep. Please check my calendar and book me for an intro call.

Or reach out by phone/email:
jcrha@rapidnovor.com
+1 (519) 279-6746

“Rapid Novor was tasked with finding highly specific, high affinity antibodies against an important target- and they delivered powerful antibodies fit-for-purpose. Such antibodies are not easily obtained yet the Rapid Novor approach proved immediately successful, despite our time-constrained and stringent demands.”

Matt Pope, VP of Client Services, SISCAPA

“We’re focused on coupling cytokines with a highly engineered VHVL of an antibody. So by sequencing the antibodies with Rapid Novor we are able to pull out the CDR to graft them into our platform and test in vitro and in vivo.”

Pavel Khrimian – Co-founder and CBO, Deka Biosciences

“The sequences have allowed us to have an “insurance policy” of sorts for critical proteins used in our various products.”

David Ankrapp, Senior Research Scientist, Neogen Corporations

Talk to Our Scientists.

We Have Sequenced 5000+ Antibodies and We Are Eager to Help You.

Through next generation protein sequencing, Rapid Novor enables reliable discovery and development of novel reagents, diagnostics, and therapeutics. Thanks to our Next Generation Protein Sequencing and antibody discovery services, researchers have furthered thousands of projects, patented antibody therapeutics, and developed the first recombinant polyclonal antibody diagnostics.

Talk to Our Scientists.

We Have Sequenced 5000+ Antibodies and We Are Eager to Help You.

Through next generation protein sequencing, Rapid Novor enables timely and reliable discovery and development of novel reagents, diagnostics, and therapeutics. Thanks to our Next Generation Protein Sequencing and antibody discovery services, researchers have furthered thousands of projects, patented antibody therapeutics, and ran the first recombinant polyclonal antibody diagnostics

Talk to our scientists. We have sequenced over 5000 antibodies and we are eager to help you.